2016 Production Schedule Trialscape maps are published based on all trial timing projections. We also offer Citeline’s editorial calendar to accommodate discounted Full Portfolio pricing that includes the inclusion of data from major conferences access to every map included in the therapeutic and anticipated industry events. area. Upon purchase, all Trialscape maps are You may purchase Trialscape maps singly or as annual subscriptions that include a base map plus two updates (for a total of three releases). Every update involves a full reassessment of the trials landscape and includes the addition of all new trials that fit the map criteria and full review/analysis of made available enterprise-wide for download through Trialtrove. For interest in areas beyond this list, customized options are available. Our analysts will work with you to create a deliverable that is tailored to your needs. To order, contact your account manager or email email@example.com. Please note that Citeline updates the Trialscape inventory map selection and content annually, based on industry interest and activity, and may edit the scope of specific maps between releases, based on area growth and other considerations. AUTOIMMUNE/INFLAMMATION Biosimilars of Adalimumab in Autoimmune/Inflammation, All Phases Feb-16 Jul-16 Feb-17 Pipeline Biologics in Psoriasis, Phase III Apr-16 Oct-16 Apr-17 Pipeline Biologics in Asthma, Phase III Jun-16 Oct-16 Jun-17 Pipeline Biologics in Rheumatoid Arthritis, Phase III Jul-16 Nov-16 Jul-17 Pipeline Kinase Inhibitors in Rheumatoid Arthritis, Phases II - III Jul-16 Nov-16 Jul-17 Pipeline Drugs for Congestive Heart Failure, Phase III Apr-16 Oct-16 Mar-17 Select Pipeline drugs for Dyslipidemia, Phase III Apr-16 Oct-16 Mar-17 Pipeline Drugs for Pulmonary Hypertension, Phase III Apr-16 Oct-16 Mar-17 Beta Amyloid Antagonists/Inhibitors in Alzheimer’s Disease, Phase III Apr-16 Nov-16 Apr-17 Oral Agents in Multiple Sclerosis, Phases II - III May-16 Nov-16 May-17 Chronic Neuropathic Pain, Phase III Jun-16 Oct-16 Jun-17 Pipeline Drugs for Respiratory Synctial Virus, Phase II-III Feb-16 Oct-16 Feb-17 HCV Direct Acting Antivirals (DAAs) - Combination Trials, Phase III May-16 Dec-16 May-17 CARDIOVASCULAR CENTRAL NERVOUS SYSTEM INFECTIOUS DISEASE & GENITOURINARY 2016 Production Schedule METABOLIC/ENDOCRINOLOGY Pipeline Drugs for Chronic Renal Anemia, Phase II Feb-16 Sep-16 Feb-17 Pipeline Drugs for Chronic Renal Anemia, Phase III Feb-16 Sep-16 Feb-17 Type 2 Diabetes CV Outcomes, All Phases Feb-16 Sep-16 Feb-17 Breast Cancer First Line Therapies, Phase III & Pivotal Phase II Jan-16 Jul-16 Jan-17 Breast Cancer Second Line or Greater Therapies, Phase III & Pivotal Phase II Jan-16 Jul-16 Jan-17 Hormone Refractory Prostate Cancer Therapies, Phase III & Pivotal Phase II Feb-16 Aug-16 Feb-17 Pancreatic Cancer Therapies, Phase III & Pivotal Phase II Feb-16 Aug-16 Feb-17 Melanoma Therapies, Phase III & Pivotal Phase II Mar-16 Sep-16 Mar-17 Ovarian Cancer Therapies, Phase III & Pivotal Phase II Mar-16 Sep-16 Mar-17 Non-Small Cell Lung Cancer Immunotherapies, Phase III & Pivotal Phase II Apr-16 Oct-16 Apr-17 ONCOLOGY www.citeline.com Citeline © 2016. All rights reserved.